Tm Bioscience to supply Tag-It tests to the University of Medicine and Dentistry of New Jersey:
This article was originally published in Clinica
Toronto, Canada-based diagnostics company Tm Bioscience has agreed to supply the University of Medicine and Dentistry of New Jersey (UMDNJ) with its Tag-It CTFR 40+4 mutation detection test for cystic fibrosis. The assay is developed to simultaneously screen for 25 cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and four variants as well as 15 of the world's most common and North American-prevalent mutations. UMDNJ says it plans to adopt Tm Bioscience's other tests which are available on the company's standardised genetic testing platform.
You may also be interested in...
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.
UK-based charity International Health Partners has launched a fresh appeal to double the value funds being raised to send essential medicines to expectant mothers and children at risk of death in areas of extreme deprivation.
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.